-
1
-
-
9444259791
-
Posttransplant lymphoproliferative disease in pediatric liver transplantation
-
Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996; 62: 370.
-
(1996)
Transplantation
, vol.62
, pp. 370
-
-
Newell, K.A.1
Alonso, E.M.2
Whitington, P.F.3
-
2
-
-
0025968957
-
The changing pattern of posttransplant malignancies
-
Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23: 1101.
-
(1991)
Transplant Proc
, vol.23
, pp. 1101
-
-
Penn, I.1
-
3
-
-
0027949036
-
Posttransplant malignancies in pediatric organ transplant recipients
-
Penn I. Posttransplant malignancies in pediatric organ transplant recipients. Transplant Proc 1994; 26: 2763.
-
(1994)
Transplant Proc
, vol.26
, pp. 2763
-
-
Penn, I.1
-
4
-
-
0025801703
-
Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern
-
Malatack JJ, Gartner JC, Urbach AH, Zitelli BJ. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern. J Pediatr 1991; 118: 667.
-
(1991)
J Pediatr
, vol.118
, pp. 667
-
-
Malatack, J.J.1
Gartner, J.C.2
Urbach, A.H.3
Zitelli, B.J.4
-
5
-
-
0345038763
-
The effect of immunosuppression on post transplant lympho-proliferative disease in pediatric liver transplant patients
-
in press
-
Younes B, McDiarmid S, Martin M, et al. The effect of immunosuppression on post transplant lympho-proliferative disease in pediatric liver transplant patients. Transplantation 1998 (in press).
-
(1998)
Transplantation
-
-
Younes, B.1
McDiarmid, S.2
Martin, M.3
-
6
-
-
0026655969
-
A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder
-
Alfrey EJ, Friedman AL, Grossman RA, et al. A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder. Transplantation 1992; 54: 250.
-
(1992)
Transplantation
, vol.54
, pp. 250
-
-
Alfrey, E.J.1
Friedman, A.L.2
Grossman, R.A.3
-
7
-
-
0027468059
-
Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders
-
Cen H, Williams PA, McWilliams HP, Breinig MC, Ho M, McKnight JL. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders. Blood 1993; 81: 1393.
-
(1993)
Blood
, vol.81
, pp. 1393
-
-
Cen, H.1
Williams, P.A.2
McWilliams, H.P.3
Breinig, M.C.4
Ho, M.5
McKnight, J.L.6
-
8
-
-
0027716846
-
Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients
-
Sokol EM, Caragiozoglou T, Lamy M, Reding R, Otte J. Epstein-Barr virus serology and Epstein-Barr virus-associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993; 56: 1394.
-
(1993)
Transplantation
, vol.56
, pp. 1394
-
-
Sokol, E.M.1
Caragiozoglou, T.2
Lamy, M.3
Reding, R.4
Otte, J.5
-
9
-
-
0023890609
-
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children
-
Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719.
-
(1988)
Transplantation
, vol.45
, pp. 719
-
-
Ho, M.1
Jaffe, R.2
Miller, G.3
-
10
-
-
0028912569
-
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation
-
Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 1995; 59: 524.
-
(1995)
Transplantation
, vol.59
, pp. 524
-
-
Cox, K.L.1
Lawrence-Miyasaki, L.S.2
Garcia-Kennedy, R.3
-
11
-
-
0028911721
-
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations
-
Walker RC, Paya CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995; 14: 214.
-
(1995)
J Heart Lung Transplant
, vol.14
, pp. 214
-
-
Walker, R.C.1
Paya, C.V.2
Marshall, W.F.3
-
12
-
-
0029847302
-
Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation
-
Reyes J, Green M, Bueno J, et al. Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc 1996; 28: 2768.
-
(1996)
Transplant Proc
, vol.28
, pp. 2768
-
-
Reyes, J.1
Green, M.2
Bueno, J.3
-
13
-
-
0029816728
-
Gastrointestinal posttransplant lymphoproliferative disease in children
-
Putnam P, Reyes J, Kocoshis S, et al. Gastrointestinal posttransplant lymphoproliferative disease in children. Transplant Proc 1996; 28: 2777.
-
(1996)
Transplant Proc
, vol.28
, pp. 2777
-
-
Putnam, P.1
Reyes, J.2
Kocoshis, S.3
-
14
-
-
0026772028
-
Experience with post-transplant lymphoproliferative disorders in solid organ transplant recipients
-
Nalesnik MA, Lacker J, Jaffe R, et al. Experience with post-transplant lymphoproliferative disorders in solid organ transplant recipients. Clin Transplant 1992; 6: 249.
-
(1992)
Clin Transplant
, vol.6
, pp. 249
-
-
Nalesnik, M.A.1
Lacker, J.2
Jaffe, R.3
-
15
-
-
0007437851
-
Management of post-transplant lymphoproliferative disorder (PTLD) in pediatric liver transplant recipients receiving primary tacrolimus (FK 506) therapy
-
Cacciarelli TV, Green M, Jaffe R, Mieles L, Fung JJ, Reyes J. Management of post-transplant lymphoproliferative disorder (PTLD) in pediatric liver transplant recipients receiving primary tacrolimus (FK 506) therapy [Abstract]. Liver Transplant Surg 1997; 3: C-47.
-
(1997)
Liver Transplant Surg
, vol.3
-
-
Cacciarelli, T.V.1
Green, M.2
Jaffe, R.3
Mieles, L.4
Fung, J.J.5
Reyes, J.6
-
16
-
-
0026061019
-
Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients
-
Renard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991; 23: 1473.
-
(1991)
Transplant Proc
, vol.23
, pp. 1473
-
-
Renard, T.H.1
Andrews, W.S.2
Foster, M.E.3
-
17
-
-
0028123515
-
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts
-
Reding R, Wallemacq PE, Lamy ME, et al. Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Transplantation 1994; 57: 93.
-
(1994)
Transplantation
, vol.57
, pp. 93
-
-
Reding, R.1
Wallemacq, P.E.2
Lamy, M.E.3
-
18
-
-
0028964649
-
The treatment of intractable rejection with FK506 in pediatric liver transplant recipients
-
McDiarmid SV, Wallace P, Vargas J, Ament ME, Busuttil RW. The treatment of intractable rejection with FK506 in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 1995; 20: 291.
-
(1995)
J Pediatr Gastroenterol Nutr
, vol.20
, pp. 291
-
-
McDiarmid, S.V.1
Wallace, P.2
Vargas, J.3
Ament, M.E.4
Busuttil, R.W.5
-
19
-
-
0028815349
-
Central nervous system lymphomas in organ allograft recipients
-
Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation 1995; 59: 240.
-
(1995)
Transplantation
, vol.59
, pp. 240
-
-
Penn, I.1
Porat, G.2
-
20
-
-
0028359981
-
Clinical characteristics of post-transplant lymphoproliferative disorders
-
Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KJ, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994; 97: 14.
-
(1994)
Am J Med
, vol.97
, pp. 14
-
-
Morrison, V.A.1
Dunn, D.L.2
Manivel, J.C.3
Gajl-Peczalska, K.J.4
Peterson, B.A.5
-
21
-
-
0029361923
-
Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders
-
Rustgi VK. Epstein-Barr viral infection and posttransplantation lymphoproliferative disorders. Liver Transplant Surg 1995; 1: 100.
-
(1995)
Liver Transplant Surg
, vol.1
, pp. 100
-
-
Rustgi, V.K.1
-
22
-
-
0027425990
-
Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient
-
Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J. Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer 1993; 72: 2568.
-
(1993)
Cancer
, vol.72
, pp. 2568
-
-
Nalesnik, M.A.1
Randhawa, P.2
Demetris, A.J.3
Casavilla, A.4
Fung, J.J.5
Locker, J.6
-
23
-
-
0028796172
-
The association of Epstein-Barr virus with smooth-muscle tumors
-
Lee ES, Locker J, Nalesnik M, et al. The association of Epstein-Barr virus with smooth-muscle tumors. N Engl J Med 1995; 332: 19.
-
(1995)
N Engl J Med
, vol.332
, pp. 19
-
-
Lee, E.S.1
Locker, J.2
Nalesnik, M.3
-
24
-
-
0031859574
-
One hundred children treated with tacrolimus after primary orthotopic liver transplantation
-
McDiarmid S, Goss J, Seu P, et al. One hundred children treated with tacrolimus after primary orthotopic liver transplantation. Transplant Proc 1998; 30: 1397.
-
(1998)
Transplant Proc
, vol.30
, pp. 1397
-
-
McDiarmid, S.1
Goss, J.2
Seu, P.3
-
25
-
-
0025366026
-
Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy
-
Randhawa PS, Markin RS, Starzl TE, Demetris AJ. Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol 1990; 14: 538.
-
(1990)
Am J Surg Pathol
, vol.14
, pp. 538
-
-
Randhawa, P.S.1
Markin, R.S.2
Starzl, T.E.3
Demetris, A.J.4
-
26
-
-
0028327807
-
Manifestations of Epstein-Barr virus-associated disorders in liver
-
Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 1994; 14: 1.
-
(1994)
Liver
, vol.14
, pp. 1
-
-
Markin, R.S.1
-
27
-
-
0021349053
-
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
-
Starzl TE, Nalesnik M, Porter KA, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583.
-
(1984)
Lancet
, vol.1
, pp. 583
-
-
Starzl, T.E.1
Nalesnik, M.2
Porter, K.A.3
-
28
-
-
0021368055
-
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus
-
Lin JC, Smith MC, Pagano JS. Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol 1984; 50: 50.
-
(1984)
J Virol
, vol.50
, pp. 50
-
-
Lin, J.C.1
Smith, M.C.2
Pagano, J.S.3
-
31
-
-
0023278445
-
Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation
-
Breinig MK, Zitelli B, Starzl TE, Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 1987; 156: 273.
-
(1987)
J Infect Dis
, vol.156
, pp. 273
-
-
Breinig, M.K.1
Zitelli, B.2
Starzl, T.E.3
-
32
-
-
0022394678
-
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection
-
Ho M, Miller G, Atchison RW, et al. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985; 152: 876.
-
(1985)
J Infect Dis
, vol.152
, pp. 876
-
-
Ho, M.1
Miller, G.2
Atchison, R.W.3
-
33
-
-
0026493860
-
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease
-
Randhawa PS, Jaffe R, Demetris AJ, et al. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 1992; 327: 1710.
-
(1992)
N Engl J Med
, vol.327
, pp. 1710
-
-
Randhawa, P.S.1
Jaffe, R.2
Demetris, A.J.3
-
34
-
-
0028962439
-
Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease
-
Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE. Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 1995; 89: 98.
-
(1995)
Br J Haematol
, vol.89
, pp. 98
-
-
Rooney, C.M.1
Loftin, S.K.2
Holladay, M.S.3
Brenner, M.K.4
Krance, R.A.5
Heslop, H.E.6
-
35
-
-
0030927507
-
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders
-
Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997; 35: 1612.
-
(1997)
J Clin Microbiol
, vol.35
, pp. 1612
-
-
Rowe, D.T.1
Qu, L.2
Reyes, J.3
-
36
-
-
0028955692
-
Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients
-
Martinez OM, Villanueva JC, Lawrence-Miyasaki LS, Quinn MB, Cox K, Krams SM. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation 1995; 59: 519.
-
(1995)
Transplantation
, vol.59
, pp. 519
-
-
Martinez, O.M.1
Villanueva, J.C.2
Lawrence-Miyasaki, L.S.3
Quinn, M.B.4
Cox, K.5
Krams, S.M.6
-
37
-
-
0029092750
-
Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease
-
Kenagy DN, Schlesinger Y, Weck K, Ritter JH, Gaudreault-Keener MM, Storch GA. Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation 1995; 60: 547.
-
(1995)
Transplantation
, vol.60
, pp. 547
-
-
Kenagy, D.N.1
Schlesinger, Y.2
Weck, K.3
Ritter, J.H.4
Gaudreault-Keener, M.M.5
Storch, G.A.6
-
38
-
-
0026689925
-
Detection of Epstein-Barr virus in the brain by the polymerase chain reaction
-
Pedneault L, Katz BZ, Miller G. Detection of Epstein-Barr virus in the brain by the polymerase chain reaction. Ann Neurol 1992; 32: 184.
-
(1992)
Ann Neurol
, vol.32
, pp. 184
-
-
Pedneault, L.1
Katz, B.Z.2
Miller, G.3
-
39
-
-
0026200683
-
Precise gene dosage determination by polymerase chain reaction: Theory, methodology, and statistical approach
-
Lubin MB, Elashoff JD, Wang SJ, Rotter JI, Toyoda H. Precise gene dosage determination by polymerase chain reaction: theory, methodology, and statistical approach. Mol Cell Probes 1991; 5: 307.
-
(1991)
Mol Cell Probes
, vol.5
, pp. 307
-
-
Lubin, M.B.1
Elashoff, J.D.2
Wang, S.J.3
Rotter, J.I.4
Toyoda, H.5
-
40
-
-
0342629995
-
PTLD and gastrointestinal manifestations of EBV infection in children following liver transplantation
-
May 26-30
-
Cao S, Cox K, Esquivel CO, et al. PTLD and gastrointestinal manifestations of EBV infection in children following liver transplantation [Abstract] American Society of Transplant Physicians, May 26-30, 1996.
-
(1996)
American Society of Transplant Physicians
-
-
Cao, S.1
Cox, K.2
Esquivel, C.O.3
-
41
-
-
0025174656
-
Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders
-
Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. Am J Surg Pathol 1990; 14 (Suppl 1): 92.
-
(1990)
Am J Surg Pathol
, vol.14
, Issue.SUPPL. 1
, pp. 92
-
-
Nalesnik, M.A.1
-
42
-
-
0028985543
-
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation
-
McDiarmid SV, Busuttil RW, Ascher NL, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 1995; 59: 530.
-
(1995)
Transplantation
, vol.59
, pp. 530
-
-
McDiarmid, S.V.1
Busuttil, R.W.2
Ascher, N.L.3
-
43
-
-
0027471351
-
Two-year experience with FK 506 in pediatric patients
-
Tzakis AG, Reyes J, Todo S, et al. Two-year experience with FK 506 in pediatric patients. Transplant Proc 1993; 25: 619.
-
(1993)
Transplant Proc
, vol.25
, pp. 619
-
-
Tzakis, A.G.1
Reyes, J.2
Todo, S.3
-
44
-
-
0029958985
-
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation
-
Cacciarelli TV, Esquivel CO, Cox KL, et al. Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. Transplantation 1996; 61: 1188.
-
(1996)
Transplantation
, vol.61
, pp. 1188
-
-
Cacciarelli, T.V.1
Esquivel, C.O.2
Cox, K.L.3
-
45
-
-
9044242096
-
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation
-
Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247.
-
(1996)
Transplantation
, vol.61
, pp. 247
-
-
Inomata, Y.1
Tanaka, K.2
Egawa, H.3
-
46
-
-
0028356401
-
Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
-
Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994; 84: 972.
-
(1994)
Blood
, vol.84
, pp. 972
-
-
Riddler, S.A.1
Breinig, M.C.2
McKnight, J.L.3
-
47
-
-
0029797303
-
Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children
-
Green M, Reyes J, Jabbour N, et al. Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant Proc 1996; 28: 2759.
-
(1996)
Transplant Proc
, vol.28
, pp. 2759
-
-
Green, M.1
Reyes, J.2
Jabbour, N.3
-
48
-
-
0028296089
-
Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease
-
Savoie A, Perpete C, Carpentier L, Joncas J, Alfieri C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994; 83: 2715.
-
(1994)
Blood
, vol.83
, pp. 2715
-
-
Savoie, A.1
Perpete, C.2
Carpentier, L.3
Joncas, J.4
Alfieri, C.5
-
49
-
-
0025333806
-
Epstein-Barr virus infection in 59 orthotopic liver transplant patients
-
Lamy M, Favart Am, Cornu C, et al. Epstein-Barr virus infection in 59 orthotopic liver transplant patients. Med Microbiol Immunol 1990; 179: 137.
-
(1990)
Med Microbiol Immunol
, vol.179
, pp. 137
-
-
Lamy, M.1
Favart, Am.2
Cornu, C.3
-
50
-
-
0028836890
-
Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis
-
Kuo PC, Dafoe DC, Alfrey EJ, Sibley RK, Scandling JD. Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis. Transplantation 1995; 59: 135.
-
(1995)
Transplantation
, vol.59
, pp. 135
-
-
Kuo, P.C.1
Dafoe, D.C.2
Alfrey, E.J.3
Sibley, R.K.4
Scandling, J.D.5
-
51
-
-
0031437776
-
Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children
-
Green M, Kaufmann M, Wilson J, Reyes J. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. Clin Infect Dis 1997; 25: 1344.
-
(1997)
Clin Infect Dis
, vol.25
, pp. 1344
-
-
Green, M.1
Kaufmann, M.2
Wilson, J.3
Reyes, J.4
-
52
-
-
0029065431
-
Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients
-
Winston DJ, Wirin D, Shaked A, Busuttil RW. Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 1995; 346: 69.
-
(1995)
Lancet
, vol.346
, pp. 69
-
-
Winston, D.J.1
Wirin, D.2
Shaked, A.3
Busuttil, R.W.4
-
53
-
-
0031441891
-
Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors
-
Seu P, Winston DJ, Holt CD, Kaldas F, Busuttil RW. Long-term ganciclovir prophylaxis for successful prevention of primary cytomegalovirus (CMV) disease in CMV-seronegative liver transplant recipients with CMV-seropositive donors. Transplantation 1997; 64: 1614.
-
(1997)
Transplantation
, vol.64
, pp. 1614
-
-
Seu, P.1
Winston, D.J.2
Holt, C.D.3
Kaldas, F.4
Busuttil, R.W.5
-
54
-
-
0030706179
-
Oral ganciclovir in pediatric transplant recipients: A pharmacokinetic study
-
Pescovitz MD, Brook B, Jindal RM, Leapman SB, Milgrom ML, Filo RS. Oral ganciclovir in pediatric transplant recipients: a pharmacokinetic study. Clin Transplant 1997; 11: 613.
-
(1997)
Clin Transplant
, vol.11
, pp. 613
-
-
Pescovitz, M.D.1
Brook, B.2
Jindal, R.M.3
Leapman, S.B.4
Milgrom, M.L.5
Filo, R.S.6
-
55
-
-
0030699421
-
Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: The role of cytomegalovirus disease
-
Manez R, Breinig MC, Linden P, et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997; 176: 1462.
-
(1997)
J Infect Dis
, vol.176
, pp. 1462
-
-
Manez, R.1
Breinig, M.C.2
Linden, P.3
-
56
-
-
0019835970
-
Epstein-Barr virus-specific serology in immunologically compromised individuals
-
Henle W, Henle G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res 1981; 41: 4222.
-
(1981)
Cancer Res
, vol.41
, pp. 4222
-
-
Henle, W.1
Henle, G.2
-
57
-
-
0027407288
-
Molecular genetic analysis of post-transplant lymphoproliferative disorders
-
Seiden MV, Sklar J. Molecular genetic analysis of post-transplant lymphoproliferative disorders. Hematol Oncol Clin North Am 1993; 7: 447.
-
(1993)
Hematol Oncol Clin North Am
, vol.7
, pp. 447
-
-
Seiden, M.V.1
Sklar, J.2
-
58
-
-
0030944613
-
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients
-
Nalesnik MA, Rao AS, Furukawa H, et al. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation 1997; 63: 1200.
-
(1997)
Transplantation
, vol.63
, pp. 1200
-
-
Nalesnik, M.A.1
Rao, A.S.2
Furukawa, H.3
|